Cohance Lifesciences Ltd. NSE: COHANCE | BSE: 543064

Cohance Lifesciences Ltd. Live Share Price Today, Share Analysis and Chart

Name: Cohance Lifesciences Ltd.: Is Infosys Ltd. worth buying?
Item: Cohance Lifesciences Ltd.
Rating: 1.88975
Author: Trendlyne DVM scores

Expensive Underperformer

about

Incorporated in 2018, Suven Pharmaceuticals is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract...

871.65 -9.20 (-1.04%)

New 52W Low today

953.9K

NSE+BSE Volume

High volume today

NSE 28 Aug, 2025 3:31 PM (IST)

Analyst Buy

Jefferies initiates coverage on Cohance Life with a ‘Buy’ rating and a target price of Rs 1,150 See details

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

50.0 / 100

Expensive Valuation

21.5 / 100

Technically Bearish

29.7 / 100

Expensive Underperformer These stocks are medium in financial scores. They have bad valuation and technical scores as well. View Similar Embed DVM

1,225

1Yr Price target upside is 41%

6 analysts

Cohance Lifesciences Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

28 Votes:

Buy 67.86%

Sell 14.29%

Hold 17.86%

Cohance Lifesciences Ltd. Live Share Price Today, Share Analysis and Chart

Incorporated in 2018, Suven Pharmaceuticals is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract...

New 52W Low today

High volume today

SWOT Analysis

Cohance Lifesciences Live Price Chart